Ranked in 2 Practice Areas
2

Band 2

Intellectual Property: Patent Litigation

London (Firms)

13 Years Ranked

2

Band 2

Ranked in Guides

About

Provided by Daniel Brook

UK

Practice Areas

Intellectual Property

Patents

Life Sciences and Healthcare

Pharmaceuticals and Biotechnology

Career

Please see https://www.hoganlovells.com/en/daniel-brook for further information.

Professional Memberships

AIPPI Council Member

CIPA

EPLAW

Languages Spoken

English

Experience

Daniel is a patent litigator in the UK. He acts for clients such as MSD, Lilly, Amgen and BMS. Recent key cases include Actavis v Lilly (Supreme Court), Schutz v Werit (Supreme Court), and BMS v Teva (availability of interim injunctions).

He has experience with each of the major patent jurisdictions in Europe. He regularly manages cross border patent litigation for clients on their most important products and has been involved in a number of leading cases.

Daniel is ranked by Chambers UK - 'Clients commend his 'high-quality counselling' and his 'clear, well-structured' communications.', Legal 500, MIP IP Stars, IAM Patent 1000 and Who's Who Legal.

Work Highlights

- Acting for MSD in relation to patent challenges around its products including simvastatin, lovastatin, alendronate and raltegravir.

- Acting for Lilly in relation to patent challenges around its oncology products including pemetrexed (Supreme Court) and gemcitabine.

- Acting for BMS in relation to patent challenges around its products, dasatinib, efavirenz and atazanavir.

- Acting for a number of electronic clients including HTC, ZTE and BlackBerry on European patent litigation matters.

Chambers Review

Provided by Chambers

Chambers Guide to the Legal Profession

Life Sciences: IP/Patent Litigation - UK-wide

2
Band 2
Individual Editorial

Daniel Brook is highly recommended for his strong practice in patent litigation, which sees him regularly advise and act for significant clients in the pharmaceutical space.


Intellectual Property: Patent Litigation - London (Firms)

2
Band 2
Individual Editorial
Daniel Brook frequently litigates complex cross-border patent disputes for large corporates in the life sciences and pharmaceutical industries. He also has experience representing aviation and engineering firms in patent litigation.

Strengths

Provided by Chambers

Discover other Lawyers at
Hogan Lovells

Provided by Chambers
Filter by
Band

London (Firms)

Commercial and Corporate Litigation

S
Chris Hardman
S
Senior Statespeople
1
Kevin Lloyd
1
Band 1
3
Alex Sciannaca
3
Band 3
3
Neil Mirchandani
3
Band 3
4
Ivan Shiu
4
Band 4
Competition Law

5
Angus Coulter
5
Band 5
Competition Law: Litigation

2
Edward Coulson
2
Band 2
2
Nicholas Heaton
2
Band 2
3
Christopher Hutton
3
Band 3
Competition Law: Private Enforcement: Claimant

1
Edward Coulson
1
Band 1
U
Andrew Leitch
U
Up and Coming
Construction: Non-contentious

1
Gillian Thomas
1
Band 1
Corporate Crime & Investigations

2
Claire Lipworth
2
Band 2
5
Liam Naidoo
5
Band 5
Olga Tocewicz
Associates to watch
Corporate/M&A: £800 million and above

5
Daniel Simons
5
Band 5
5
Nicola Evans
5
Band 5
Francesca Parker
Associates to watch
Employment: Employer

2
Stefan Martin
2
Band 2
3
Edward Bowyer
3
Band 3
20 of 137 results

Key Sectors

Provided by Hogan Lovells

Health and Life Sciences

Technology, Media and Telecoms (TMT)